$ESRX Express Scripts Holding Co. Insider Trading Week 10/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Express Scripts Holding Co..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Express Scripts Holding Co. in week 10/2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14 2014 | ESRX | Express Scripts Ho ... | Houston Christine | Sr. Vice President, ... | Option Exercise | M | 31.92 | 12,028 | 383,934 | 0 | |
| Mar 14 2014 | ESRX | Express Scripts Ho ... | Houston Christine | Sr. Vice President, ... | Option Exercise | M | 31.92 | 3,646 | 116,380 | 0 | |
| Mar 14 2014 | ESRX | Express Scripts Ho ... | Houston Christine | Sr. Vice President, ... | Sell | S | 78.53 | 19,757 | 1,551,458 | 18,314 | 38.1 K to 18.3 K (-51.90 %) |
| Mar 14 2014 | ESRX | Express Scripts Ho ... | Houston Christine | Sr. Vice President, ... | Buy | M | 31.92 | 12,028 | 383,934 | 38,071 | 26 K to 38.1 K (+46.19 %) |
| Mar 14 2014 | ESRX | Express Scripts Ho ... | Houston Christine | Sr. Vice President, ... | Buy | M | 31.92 | 3,646 | 116,380 | 26,043 | 22.4 K to 26 K (+16.28 %) |
| Mar 13 2014 | ESRX | Express Scripts Ho ... | IGNACZAK EDWARD B | Exec. VP, Sales and ... | Option Exercise | M | 53.05 | 13,680 | 725,724 | 0 | |
| Mar 13 2014 | ESRX | Express Scripts Ho ... | IGNACZAK EDWARD B | Exec. VP, Sales and ... | Option Exercise | M | 53.05 | 41,434 | 2,198,074 | 20,719 | |
| Mar 13 2014 | ESRX | Express Scripts Ho ... | IGNACZAK EDWARD B | Exec. VP, Sales and ... | Option Exercise | M | 58.17 | 16,016 | 931,651 | 32,032 | |
| Mar 13 2014 | ESRX | Express Scripts Ho ... | IGNACZAK EDWARD B | Exec. VP, Sales and ... | Option Exercise | M | 56.50 | 49,117 | 2,775,111 | 0 | |
| Mar 13 2014 | ESRX | Express Scripts Ho ... | IGNACZAK EDWARD B | Exec. VP, Sales and ... | Sell | S | 78.54 | 120,247 | 9,443,839 | 85,882 | 206.1 K to 85.9 K (-58.34 %) |
| Mar 13 2014 | ESRX | Express Scripts Ho ... | IGNACZAK EDWARD B | Exec. VP, Sales and ... | Buy | M | 53.05 | 13,680 | 725,724 | 206,129 | 192.4 K to 206.1 K (+7.11 %) |
| Mar 13 2014 | ESRX | Express Scripts Ho ... | IGNACZAK EDWARD B | Exec. VP, Sales and ... | Buy | M | 53.05 | 41,434 | 2,198,074 | 192,449 | 151 K to 192.4 K (+27.44 %) |
| Mar 13 2014 | ESRX | Express Scripts Ho ... | IGNACZAK EDWARD B | Exec. VP, Sales and ... | Buy | M | 58.17 | 16,016 | 931,651 | 151,015 | 135 K to 151 K (+11.86 %) |
| Mar 13 2014 | ESRX | Express Scripts Ho ... | IGNACZAK EDWARD B | Exec. VP, Sales and ... | Buy | M | 56.50 | 49,117 | 2,775,111 | 134,999 | 85.9 K to 135 K (+57.19 %) |
| Mar 13 2014 | ESRX | Express Scripts Ho ... | Norton David A | Senior VP, Supply C ... | Sell | S | 79.16 | 1,580 | 125,076 | 630 | 2.2 K to 630 (-71.49 %) |
| Mar 13 2014 | ESRX | Express Scripts Ho ... | Norton David A | Senior VP, Supply C ... | Sell | S | 79.14 | 1,580 | 125,048 | 646 | 2.2 K to 646 (-70.98 %) |
| Mar 12 2014 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Sell | S | 77.96 | 12,664 | 987,298 | 21,417 | 34.1 K to 21.4 K (-37.16 %) |
| Mar 12 2014 | ESRX | Express Scripts Ho ... | McNamee Patrick | Exec. VP and COO | Sell | S | 78.22 | 27,981 | 2,188,562 | 7,664 | 35.6 K to 7.7 K (-78.50 %) |
| Mar 12 2014 | ESRX | Express Scripts Ho ... | McNamee Patrick | Exec. VP and COO | Sell | S | 78.32 | 40,444 | 3,167,695 | 12,421 | 52.9 K to 12.4 K (-76.50 %) |
| Mar 11 2014 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Option Exercise | M | 47.61 | 21,800 | 1,037,898 | 43,413 | |
| Mar 11 2014 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Option Exercise | M | 46.49 | 15,631 | 726,685 | 0 | |
| Mar 11 2014 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Sell | S | 78.21 | 43,267 | 3,383,912 | 19,857 | 63.1 K to 19.9 K (-68.54 %) |
| Mar 11 2014 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Sell | S | 78.65 | 500 | 39,327 | 63,124 | 63.6 K to 63.1 K (-0.79 %) |
| Mar 11 2014 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Buy | M | 47.61 | 21,800 | 1,037,898 | 63,624 | 41.8 K to 63.6 K (+52.12 %) |
| Mar 11 2014 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Buy | M | 46.49 | 15,631 | 726,685 | 41,824 | 26.2 K to 41.8 K (+59.68 %) |
| Mar 11 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Option Exercise | M | 49.50 | 9,901 | 490,050 | 0 | |
| Mar 11 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Sell | S | 79.00 | 9,582 | 756,978 | 20,000 | 29.6 K to 20 K (-32.39 %) |
| Mar 11 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Sell | S | 78.50 | 16,139 | 1,266,928 | 22,222 | 38.4 K to 22.2 K (-42.07 %) |
| Mar 11 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Buy | M | 49.50 | 9,901 | 490,050 | 38,361 | 28.5 K to 38.4 K (+34.79 %) |